191 related articles for article (PubMed ID: 12805480)
21. Molecular mechanisms of cannabinoid protection from neuronal excitotoxicity.
Kim SH; Won SJ; Mao XO; Jin K; Greenberg DA
Mol Pharmacol; 2006 Mar; 69(3):691-6. PubMed ID: 16299067
[TBL] [Abstract][Full Text] [Related]
22. Inhibition of small intestinal secretion by cannabinoids is CB1 receptor-mediated in rats.
Tyler K; Hillard CJ; Greenwood-Van Meerveld B
Eur J Pharmacol; 2000 Dec; 409(2):207-11. PubMed ID: 11104836
[TBL] [Abstract][Full Text] [Related]
23. Cannabinoid CB(2) receptor activation prevents bronchoconstriction and airway oedema in a model of gastro-oesophageal reflux.
Cui YY; D'Agostino B; Risse PA; Marrocco G; Naline E; Zhang Y; Chen HZ; Finance O; Rinaldi-Carmona M; Rossi F; Advenier C
Eur J Pharmacol; 2007 Nov; 573(1-3):206-13. PubMed ID: 17643417
[TBL] [Abstract][Full Text] [Related]
24. Inhibitory effects of SR141716A on G-protein activation in rat brain.
Sim-Selley LJ; Brunk LK; Selley DE
Eur J Pharmacol; 2001 Mar; 414(2-3):135-43. PubMed ID: 11239913
[TBL] [Abstract][Full Text] [Related]
25. Cannabinoid receptor-mediated apoptosis induced by R(+)-methanandamide and Win55,212-2 is associated with ceramide accumulation and p38 activation in mantle cell lymphoma.
Gustafsson K; Christensson B; Sander B; Flygare J
Mol Pharmacol; 2006 Nov; 70(5):1612-20. PubMed ID: 16936228
[TBL] [Abstract][Full Text] [Related]
26. A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide.
Benamar K; Yondorf M; Meissler JJ; Geller EB; Tallarida RJ; Eisenstein TK; Adler MW
J Pharmacol Exp Ther; 2007 Mar; 320(3):1127-33. PubMed ID: 17194800
[TBL] [Abstract][Full Text] [Related]
27. Sphingosine and its analog, the immunosuppressant 2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol, interact with the CB1 cannabinoid receptor.
Paugh SW; Cassidy MP; He H; Milstien S; Sim-Selley LJ; Spiegel S; Selley DE
Mol Pharmacol; 2006 Jul; 70(1):41-50. PubMed ID: 16571654
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the role of CB1 receptors in cannabinoid anticonvulsant effects.
Wallace MJ; Wiley JL; Martin BR; DeLorenzo RJ
Eur J Pharmacol; 2001 Sep; 428(1):51-7. PubMed ID: 11779037
[TBL] [Abstract][Full Text] [Related]
29. Antitumor effects of cannabidiol, a nonpsychoactive cannabinoid, on human glioma cell lines.
Massi P; Vaccani A; Ceruti S; Colombo A; Abbracchio MP; Parolaro D
J Pharmacol Exp Ther; 2004 Mar; 308(3):838-45. PubMed ID: 14617682
[TBL] [Abstract][Full Text] [Related]
30. Characterization of cannabinoid modulation of sensory neurotransmission in the rat isolated mesenteric arterial bed.
Duncan M; Kendall DA; Ralevic V
J Pharmacol Exp Ther; 2004 Oct; 311(1):411-9. PubMed ID: 15205450
[TBL] [Abstract][Full Text] [Related]
31. A cyclooxygenase metabolite of anandamide causes inhibition of interleukin-2 secretion in murine splenocytes.
Rockwell CE; Kaminski NE
J Pharmacol Exp Ther; 2004 Nov; 311(2):683-90. PubMed ID: 15284281
[TBL] [Abstract][Full Text] [Related]
32. Regulation of inflammatory pain by inhibition of fatty acid amide hydrolase.
Naidu PS; Kinsey SG; Guo TL; Cravatt BF; Lichtman AH
J Pharmacol Exp Ther; 2010 Jul; 334(1):182-90. PubMed ID: 20375198
[TBL] [Abstract][Full Text] [Related]
33. Cannabinoid receptor agonists inhibit Ca(2+) influx to synaptosomes from rat brain.
Yoshihara S; Morimoto H; Ohori M; Yamada Y; Abe T; Arisaka O
Pharmacology; 2006; 76(4):157-62. PubMed ID: 16446560
[TBL] [Abstract][Full Text] [Related]
34. Inhibitory effect of cannabinoid agonists on gastric emptying in the rat.
Izzo AA; Mascolo N; Capasso R; Germanò MP; De Pasquale R; Capasso F
Naunyn Schmiedebergs Arch Pharmacol; 1999 Aug; 360(2):221-3. PubMed ID: 10494894
[TBL] [Abstract][Full Text] [Related]
35. Cannabinoid regulation of nitric oxide synthase I (nNOS) in neuronal cells.
Carney ST; Lloyd ML; MacKinnon SE; Newton DC; Jones JD; Howlett AC; Norford DC
J Neuroimmune Pharmacol; 2009 Sep; 4(3):338-49. PubMed ID: 19365734
[TBL] [Abstract][Full Text] [Related]
36. Selective cannabinoid CB1 receptor-mediated inhibition of inducible nitric oxide synthase protein expression in C6 rat glioma cells.
Esposito G; Izzo AA; Di Rosa M; Iuvone T
J Neurochem; 2001 Aug; 78(4):835-41. PubMed ID: 11520904
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of the role of nicotinic acetylcholine receptor subtypes and cannabinoid system in the discriminative stimulus effects of nicotine in rats.
Zaniewska M; McCreary AC; Przegaliński E; Filip M
Eur J Pharmacol; 2006 Jul; 540(1-3):96-106. PubMed ID: 16730696
[TBL] [Abstract][Full Text] [Related]
38. Effects of 2-arachidonylglycerol, an endogenous cannabinoid, on neuronal activity in rat hippocampal slices.
Ameri A; Simmet T
Naunyn Schmiedebergs Arch Pharmacol; 2000 Mar; 361(3):265-72. PubMed ID: 10731038
[TBL] [Abstract][Full Text] [Related]
39. Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation.
Darmani NA; Sim-Selley LJ; Martin BR; Janoyan JJ; Crim JL; Parekh B; Breivogel CS
Eur J Pharmacol; 2003 Jan; 459(1):83-95. PubMed ID: 12505537
[TBL] [Abstract][Full Text] [Related]
40. Modulation of gastric emptying and gastrointestinal transit in rats through intestinal cannabinoid CB(1) receptors.
Landi M; Croci T; Rinaldi-Carmona M; Maffrand JP; Le Fur G; Manara L
Eur J Pharmacol; 2002 Aug; 450(1):77-83. PubMed ID: 12176112
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]